{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:47:00Z","timestamp":1791884820719,"version":"4.3.4"},"reference-count":39,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K22821"],"award-info":[{"award-number":["20K22821"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H03063"],"award-info":[{"award-number":["22H03063"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K24324"],"award-info":[{"award-number":["23K24324"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016211","name":"Naito Science and Engineering Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016211","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["pathsocjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pathology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pancreatic ductal adenocarcinoma (PDAC) with anaplastic features is a rare and highly aggressive subtype with an extremely poor prognosis. However, the molecular mechanisms underlying anaplastic transformation remain poorly understood. To characterize the anaplastic transformation molecular landscape, we analyzed genomic alterations in 5,997 conventional PDAC and 41 anaplastic carcinoma cases from the Memorial Sloan Kettering\u2010Integrated Mutation Profiling of Actionable Cancer Targets (MSK\u2010IMPACT) cohort. Additionally, four PDAC samples from the Kyorin cohort with both tubular and anaplastic components were subjected to spatial transcriptomics using the Visium platform. Differential gene expression and pathway enrichment analyses were performed to identify key molecular drivers. Genomic analysis revealed higher\n                    <jats:italic>KRAS<\/jats:italic>\n                    (90 versus 75%),\n                    <jats:italic>TP53<\/jats:italic>\n                    (85 versus 60%), and\n                    <jats:italic>CDKN2A<\/jats:italic>\n                    (50 versus 30%) mutation frequencies, but notably fewer\n                    <jats:italic>SMAD4<\/jats:italic>\n                    mutations (5 versus 20%;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.022), in anaplastic carcinoma than in conventional PDAC. Spatial transcriptomics identified distinct molecular signatures, with epithelial\u2013mesenchymal transition (EMT) pathways significantly enriched in anaplastic regions. Levels of\n                    <jats:italic>ELF3<\/jats:italic>\n                    , an epithelial transcription factor, were consistently downregulated in all anaplastic components. Importantly, we detected a strong inverse correlation between\n                    <jats:italic>SMAD4<\/jats:italic>\n                    and\n                    <jats:italic>ELF3<\/jats:italic>\n                    expression in both the bulk RNA sequencing cohort and spatial transcriptomic data. Functional validation using the KC\u2010shSmad4 mouse model demonstrated that increased\n                    <jats:italic>Smad4<\/jats:italic>\n                    suppressed\n                    <jats:italic>Elf3<\/jats:italic>\n                    expression and promoted mesenchymal reprogramming. Our findings suggest a novel SMAD4\u2013ELF3 regulatory axis that may contribute to anaplastic transformation in PDAC. The retention of SMAD4 functions coupled with ELF3 downregulation may promote EMT and contribute to tumor dedifferentiation. This SMAD4\u2013ELF3 regulatory axis may provide a framework for identifying therapeutic vulnerabilities in this aggressive PDAC variant and further highlight the utility of spatial transcriptomics for understanding tumor heterogeneity. \u00a9 2026 The Pathological Society of Great Britain and Ireland.\n                  <\/jats:p>","DOI":"10.1002\/path.70136","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:02:21Z","timestamp":1791882141000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular landscape of anaplastic transformation in pancreatic ductal adenocarcinoma"],"prefix":"10.1002","author":[{"given":"Akimasa","family":"Hayashi","sequence":"first","affiliation":[{"name":"Department of Pathology Kyorin University School of Medicine  Mitaka Tokyo Japan"},{"name":"Laboratory for Cancer Genomics RIKEN Center for Integrative Medical Sciences  Yokohama Kanagawa Japan"},{"name":"Department of Integrative Physiology Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shota","family":"Sasagawa","sequence":"additional","affiliation":[{"name":"Laboratory for Cancer Genomics RIKEN Center for Integrative Medical Sciences  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Shibayama","sequence":"additional","affiliation":[{"name":"Department of Pathology Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaloyan M","family":"Tsanov","sequence":"additional","affiliation":[{"name":"Cancer Biology &amp; Genetics Program Memorial Sloan Kettering Cancer Center  New York NY USA"},{"name":"Ben May Department of Cancer Research the University of Chicago  Chicago IL USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Umeda","sequence":"additional","affiliation":[{"name":"The David M. Rubenstein Center for Pancreatic Cancer Research, Sloan Kettering Institute Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu\u2010Jui","family":"Ho","sequence":"additional","affiliation":[{"name":"Cancer Biology &amp; Genetics Program Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Department of Pathology Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wungki","family":"Park","sequence":"additional","affiliation":[{"name":"The David M. Rubenstein Center for Pancreatic Cancer Research, Sloan Kettering Institute Memorial Sloan Kettering Cancer Center  New York NY USA"},{"name":"Department of Medicine, Gastrointestinal Oncology Service Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyotaka","family":"Nagahama","sequence":"additional","affiliation":[{"name":"Department of Pathology Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Onizuka","sequence":"additional","affiliation":[{"name":"Department of Pathology Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Hibiya","sequence":"additional","affiliation":[{"name":"Department of Pathology Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaishi","family":"Satomi","sequence":"additional","affiliation":[{"name":"Department of Pathology Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry P","family":"Melchor","sequence":"additional","affiliation":[{"name":"The David M. Rubenstein Center for Pancreatic Cancer Research, Sloan Kettering Institute Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and General Surgery Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W","family":"Lowe","sequence":"additional","affiliation":[{"name":"Cancer Biology &amp; Genetics Program Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen M","family":"O'Reilly","sequence":"additional","affiliation":[{"name":"The David M. Rubenstein Center for Pancreatic Cancer Research, Sloan Kettering Institute Memorial Sloan Kettering Cancer Center  New York NY USA"},{"name":"Department of Medicine, Gastrointestinal Oncology Service Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A","family":"Iacobuzio\u2010Donahue","sequence":"additional","affiliation":[{"name":"The David M. Rubenstein Center for Pancreatic Cancer Research, Sloan Kettering Institute Memorial Sloan Kettering Cancer Center  New York NY USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidewaki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Laboratory for Cancer Genomics RIKEN Center for Integrative Medical Sciences  Yokohama Kanagawa Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Shibahara","sequence":"additional","affiliation":[{"name":"Department of Pathology Kyorin University School of Medicine  Mitaka Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop TF","year":"2025","journal-title":"Lancet"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park W","year":"2021","journal-title":"JAMA"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/adpa.2001.25404","article-title":"A clinicopathologic and immunohistochemical study of 35 anaplastic carcinomas of the pancreas with a review of the literature","volume":"5","author":"Paal E","year":"2001","journal-title":"Ann Diagn Pathol"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1093\/jjco\/hyad062","article-title":"Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment","volume":"53","author":"Imaoka H","year":"2023","journal-title":"Jpn J Clin Oncol"},{"key":"e_1_2_8_6_1","volume-title":"Digestive System Tumours: WHO Classification of Tumours, Volume 1","author":"WHO Classification of Tumours","year":"2019"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jamcollsurg.2012.06.418","article-title":"Clinical outcomes for anaplastic pancreatic cancer: a population\u2010based study","volume":"215","author":"Clark CJ","year":"2012","journal-title":"J Am Coll Surg"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-020-07462-4","article-title":"Clinical outcomes of chemotherapy in patients with undifferentiated carcinoma of the pancreas: a retrospective multicenter cohort study","volume":"20","author":"Imaoka H","year":"2020","journal-title":"BMC Cancer"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/MPA.0000000000001199","article-title":"Expression of epithelial\u2010mesenchymal transition proteins in pancreatic anaplastic (undifferentiated) carcinoma","volume":"48","author":"Ishida K","year":"2019","journal-title":"Pancreas"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jhbp.429","article-title":"Analysis of the origin of anaplastic pancreatic cancer and the mechanism of its dedifferentiation","volume":"24","author":"Miura K","year":"2017","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.630086","article-title":"Undifferentiated pancreatic carcinoma with osteoclast\u2010like giant cells: what do we know so far?","volume":"11","author":"Demetter P","year":"2021","journal-title":"Front Oncol"},{"key":"e_1_2_8_12_1","first-page":"745","article-title":"Phenotypical characteristics of undifferentiated carcinoma of the pancreas: a comparison with pancreatic ductal adenocarcinoma and relevance of E\u2010cadherin, alpha catenin and beta catenin expression","volume":"8","author":"Yonemasu H","year":"2001","journal-title":"Oncol Rep"},{"key":"e_1_2_8_13_1","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-022-01596-8","article-title":"Single\u2010cell RNA\u2010seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast\u2010like giant\u2010cells","volume":"21","author":"Wang X","year":"2022","journal-title":"Mol Cancer"},{"key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41592-022-01494-3","article-title":"Publisher correction: museum of spatial transcriptomics","volume":"19","author":"Moses L","year":"2022","journal-title":"Nat Methods"},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1096-9896(199805)185:1<53::AID-PATH45>3.0.CO;2-F","article-title":"Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki\u2010ras mutations provides evidence of a ductal origin","volume":"185","author":"Hoorens A","year":"1998","journal-title":"J Pathol"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228841","article-title":"Morphologic and molecular landscape of pancreatic cancer variants as the basis of new therapeutic strategies for precision oncology","volume":"21","author":"Bazzichetto C","year":"2020","journal-title":"Int J Mol Sci"},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00535-023-01986-9","article-title":"Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan","volume":"58","author":"Sakakida T","year":"2023","journal-title":"J Gastroenterol"},{"key":"e_1_2_8_18_1","volume-title":"World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Participants","author":"World Medical Association","year":"2024"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","article-title":"Memorial Sloan Kettering\u2010Integrated Mutation Profiling of Actionable Cancer Targets (MSK\u2010IMPACT): a hybridization capture\u2010based next\u2010generation sequencing clinical assay for solid tumor molecular oncology","volume":"17","author":"Cheng DT","year":"2015","journal-title":"J Mol Diagn"},{"key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41379-020-0549-5","article-title":"Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma","volume":"33","author":"Hayashi A","year":"2020","journal-title":"Mod Pathol"},{"key":"e_1_2_8_21_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s43018-019-0010-1","article-title":"A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma","volume":"1","author":"Hayashi A","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"e_1_2_8_22_1","article-title":"ChIP\u2010atlas: a data\u2010mining suite powered by full integration of public ChIP\u2010seq data","volume":"19","author":"Oki S","year":"2018","journal-title":"EMBO Rep"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1038\/s43018-025-01047-5","article-title":"SMAD4 induces opposite effects on metastatic growth from pancreatic tumors depending on the organ of residence","volume":"6","author":"Tsanov KM","year":"2025","journal-title":"Nat Rev Cancer"},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040973","article-title":"The role of SMAD4 inactivation in epithelial\u2013mesenchymal plasticity of pancreatic ductal adenocarcinoma: the missing link?","volume":"14","author":"Racu M\u2010L","year":"2022","journal-title":"Cancers (Basel)"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1158\/2159-8290.CD-24-0772","article-title":"Convergence for inactivation of TGF\u2010\u03b2 signaling is a common feature of advanced pancreatic cancer","volume":"16","author":"Hong J","year":"2026","journal-title":"Cancer Discov"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.cell.2016.01.009","article-title":"TGF\u2010\u03b2 tumor suppression through a lethal EMT","volume":"164","author":"David CJ","year":"2016","journal-title":"Cell"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47416-w","article-title":"Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture","volume":"9","author":"Shichi Y","year":"2019","journal-title":"Sci Rep"},{"key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1158\/0008-5472.CAN-19-2988","article-title":"E74\u2010like factor 3 is a key regulator of epithelial integrity and immune response genes in biliary tract cancer","volume":"81","author":"Suzuki M","year":"2020","journal-title":"Cancer Res"},{"key":"e_1_2_8_29_1","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080858","article-title":"The transcription factor Elf3 is essential for a successful mesenchymal to epithelial transition","volume":"8","author":"Sengez B","year":"2019","journal-title":"Cells"},{"key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"16951","DOI":"10.18632\/oncotarget.15208","article-title":"ELF3 is a negative regulator of epithelial\u2010mesenchymal transition in ovarian cancer cells","volume":"8","author":"Yeung T\u2010L","year":"2017","journal-title":"Oncotarget"},{"key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","article-title":"Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma","volume":"29","author":"Yachida S","year":"2016","journal-title":"Cancer Cell"},{"key":"e_1_2_8_32_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103534","article-title":"SMAD4 and the TGF\u03b2 pathway in patients with pancreatic ductal adenocarcinoma","volume":"21","author":"Dardare J","year":"2020","journal-title":"Int J Mol Sci"},{"key":"e_1_2_8_33_1","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1016\/j.celrep.2015.02.014","article-title":"ErbB2 pathway activation upon Smad4 loss promotes lung tumor growth and metastasis","volume":"10","author":"Liu J","year":"2015","journal-title":"Cell Rep"},{"key":"e_1_2_8_34_1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.bbrc.2006.03.236","article-title":"TGF\u2010beta signaling pathway inactivation and cell cycle deregulation in the development of gastric cancer: role of the beta\u2010spectrin, ELF","volume":"344","author":"Kim SS","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/s41467-020-16066-2","article-title":"Context specificity of the EMT transcriptional response","volume":"11","author":"Cook DP","year":"2020","journal-title":"Nat Commun"},{"key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cytogfr.2025.05.004","article-title":"TGF\u2010\u03b2\u2010driven EMT in cancer progression and drug resistance","volume":"85","author":"Luo W","year":"2025","journal-title":"Cytokine Growth Factor Rev"},{"key":"e_1_2_8_37_1","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.2147\/OTT.S248507","article-title":"The miR\u20101224\u20105p\/ELF3 axis regulates malignant behaviors of pancreatic cancer via PI3K\/AKT\/Notch signaling pathways","volume":"13","author":"Kong L","year":"2020","journal-title":"Onco Targets Ther"},{"key":"e_1_2_8_38_1","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-181","article-title":"SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells","volume":"14","author":"Chen Y\u2010W","year":"2014","journal-title":"BMC Cancer"},{"key":"e_1_2_8_39_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33037-x","article-title":"An EGFR\/HER2\u2010targeted conjugate sensitizes gemcitabine\u2010sensitive and resistant pancreatic cancer through different SMAD4\u2010mediated mechanisms","volume":"13","author":"Yao H","year":"2022","journal-title":"Nat Commun"},{"key":"e_1_2_8_40_1","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jtho.2015.12.034","article-title":"ELF3 amplification at 1q32.1 promotes SMAD4\u2010independent tumorigenesis","volume":"11","author":"Enfield KSS","year":"2016","journal-title":"J Thorac Oncol"}],"container-title":["The Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/path.70136","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/path.70136","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/path.70136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:02:27Z","timestamp":1791882147000},"score":1,"resource":{"primary":{"URL":"https:\/\/pathsocjournals.onlinelibrary.wiley.com\/doi\/10.1002\/path.70136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":39,"alternative-id":["10.1002\/path.70136"],"URL":"https:\/\/doi.org\/10.1002\/path.70136","archive":["Portico"],"relation":{},"ISSN":["0022-3417","1096-9896"],"issn-type":[{"value":"0022-3417","type":"print"},{"value":"1096-9896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"2025-11-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"path.70136"}}